SCHEMBL19000685

SCHEMBL19000685

CCOC(=O)COC(=O)c1ccccc1-c1c2ccc(=[N+](CC)CC)cc-2oc2cc(N(CC)CC)ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ BLM P54132 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ POLB P06746 1/20 0.54
▸ PPARG P37231 1/20 0.54
▸ RXFP1 Q9HBX9 1/20 0.54
▸ NCOR2 Q9Y618 1/20 0.54
▸ FPR2 P25090 4/20 0.49
▸ TGM2 P21980 1/20 0.48
▸ CHRM1 P11229 1/20 0.44
▸ ATM Q13315 2/20 0.42
▸ THRB P10828 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10298327 0.94 USP2 (0.58) USP2MEN1BLMKMT2APOLB
Hydrochloric Acid SCHEMBL23064866 0.93 USP2 (0.57) USP2MEN1BLMKMT2APOLB
SCHEMBL15627371 0.91 MEN1 (0.52) USP2MEN1BLMKMT2APOLB
Perchlorate SCHEMBL9638625 0.91 USP2 (0.57) USP2MEN1BLMKMT2APOLB
SCHEMBL10124264 0.89 USP2 (0.56) USP2MEN1BLMKMT2APOLB
SCHEMBL13033323 0.89 USP2 (0.58) USP2MEN1BLMKMT2APOLB
SCHEMBL9007850 0.88 USP2 (0.59) USP2MEN1BLMKMT2APOLB
SCHEMBL22292200 0.88 USP2 (0.55) USP2MEN1BLMKMT2APOLB
SCHEMBL18350817 0.88 USP2 (0.55) USP2MEN1BLMKMT2APOLB
SCHEMBL14393084 0.88 USP2 (0.58) USP2MEN1BLMKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3391056-B1 CHROMOGENIC PEROXIDASE SUBSTRATES AGILENT TECHNOLOGIES INC (US) 2024-01-17 — — EP disclosed
US-20170175178-A1 CHROMOGENIC PEROXIDASE SUBSTRATES DAKO DENMARK APS (DK) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170175178-A1 CHROMOGENIC PEROXIDASE SUBSTRATES MPO, TPO, TYR USP2 2528/4885MEN1 3360/4885BLM 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback